I also don't understand how you know more than Aegis? They would have gone through Slilatys history during the audit. I can't imagine they didn't think to look into previous companies.
You did so much research, here's the DD on your complete lie (thanks to a friend here that actually DOES research):
Sunshine bought the UNDEVELOPED patent and then developed it for the past 11 years, it was posted the scientific journals many times. The inventor didn’t have the means to develop it which is a common scenario for many patents!
Follow the developments. This is the FIRST PR issued after we got our partner and started to develop adva-27a…. We also gained a China drug supplier…
This was our last report from our drug partnerships discovery and it is MASSIVE!!! After this we decided to up-list to Nasdaq…..
“The implications of this development are vast in the context of cancer therapy as a whole,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “We are excited to soon have a new drug available for cancer sufferers around the world,” he added.“